Adage Capital Partners’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
+3,191,000
| New | +$30.4M | 0.05% | 348 |
|
|
2025
Q1 | – | Sell |
-1,950,000
| Closed | -$45.9M | – | 867 |
|
|
2024
Q4 | $45.9M | Sell |
1,950,000
-452,972
| -19% | -$10.7M | 0.08% | 233 |
|
|
2024
Q3 | $86.3M | Sell |
2,402,972
-925,028
| -28% | -$33.2M | 0.15% | 134 |
|
|
2024
Q2 | $117M | Buy |
3,328,000
+1,003,000
| +43% | +$35.4M | 0.22% | 84 |
|
|
2024
Q1 | $66M | Buy |
+2,325,000
| New | +$66M | 0.12% | 179 |
|
|
2023
Q3 | – | Sell |
-100,000
| Closed | -$1.13M | – | 886 |
|
|
2023
Q2 | $1.13M | Sell |
100,000
-500,000
| -83% | -$5.63M | ﹤0.01% | 763 |
|
|
2023
Q1 | $6.91M | Buy |
600,000
+200,000
| +50% | +$2.3M | 0.02% | 673 |
|
|
2022
Q4 | $4.64M | Sell |
400,000
-50,000
| -11% | -$580K | 0.01% | 757 |
|
|
2022
Q3 | $5.72M | Sell |
450,000
-120,000
| -21% | -$1.52M | 0.01% | 761 |
|
|
2022
Q2 | $3.92M | Sell |
570,000
-180,000
| -24% | -$1.24M | 0.01% | 828 |
|
|
2022
Q1 | $7.23M | Buy |
750,000
+650,000
| +650% | +$6.27M | 0.01% | 782 |
|
|
2021
Q4 | $1.19M | Buy |
100,000
+50,000
| +100% | +$595K | ﹤0.01% | 893 |
|
|
2021
Q3 | $812K | Sell |
50,000
-50,000
| -50% | -$812K | ﹤0.01% | 921 |
|
|
2021
Q2 | $2.1M | Buy |
+100,000
| New | +$2.1M | ﹤0.01% | 878 |
|